1	Glucocorticoid-induced	glucocorticoid-induced	_	_	_	_	_	_	_
2	apoptosis	apoptosis	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	regulation	regulation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	leukemic	leukemic	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Glucocorticoid-induced	glucocorticoid-induced	_	_	_	_	_	_	_
2	apoptosis	apoptosis	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	investigated	investigate	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	glucocorticoid-sensitive	glucocorticoid-sensitive	_	_	_	_	_	_	_
7	6TG1.1	6tg1.1	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	resistant	resistant	_	_	_	_	_	_	_
10	ICR27TK.3	icr27tk.3	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	leukemic	leukemic	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Following	follow	_	_	_	_	_	_	_
2	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
3	treatment	treatment	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	6TG1.1	6tg1.1	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	chromatin	chromatin	_	_	_	_	_	_	_
9	fragmentation	fragmentation	_	_	_	_	_	_	_
10	was	be	_	_	_	_	_	_	_
11	observed	observe	_	_	_	_	_	_	_
12	after	after	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	delay	delay	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	24	24	_	_	_	_	_	_	_
17	h.	h.	_	_	_	_	_	_	_
18	Fragmentation	Fragmentation	_	_	_	_	_	_	_
19	was	be	_	_	_	_	_	_	_
20	not	not	_	_	_	_	_	_	_
21	observed	observe	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	ICR27TK.3	icr27tk.3	_	_	_	_	_	_	_
24	cells	cell	_	_	_	_	_	_	_
25	containing	contain	_	_	_	_	_	_	_
26	mutant	mutant	_	_	_	_	_	_	_
27	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
28	receptors	receptor	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	L753F	L753F	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	that	that	_	_	_	_	_	_	_
33	are	be	_	_	_	_	_	_	_
34	activation-deficient	activation-deficient	_	_	_	_	_	_	_
35	but	but	_	_	_	_	_	_	_
36	retain	retain	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	ability	ability	_	_	_	_	_	_	_
39	to	to	_	_	_	_	_	_	_
40	repress	repress	_	_	_	_	_	_	_
41	AP-1	ap-1	_	_	_	_	_	_	_
42	activity	activity	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	Nor	nor	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	fragmentation	fragmentation	_	_	_	_	_	_	_
4	observed	observe	_	_	_	_	_	_	_
5	after	after	_	_	_	_	_	_	_
6	treatment	treatment	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	RU38486	RU38486	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	indicating	indicate	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	repression	repression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	AP-1	ap-1	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	not	not	_	_	_	_	_	_	_
18	involved	involve	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	As	as	_	_	_	_	_	_	_
2	described	describe	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	other	other	_	_	_	_	_	_	_
5	systems	system	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	fragmentation	fragmentation	_	_	_	_	_	_	_
8	required	require	_	_	_	_	_	_	_
9	ongoing	ongoing	_	_	_	_	_	_	_
10	protein	protein	_	_	_	_	_	_	_
11	synthesis	synthesis	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	inhibition	inhibition	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	protein	protein	_	_	_	_	_	_	_
6	synthesis	synthesis	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	cycloheximide	cycloheximide	_	_	_	_	_	_	_
9	anytime	anytime	_	_	_	_	_	_	_
10	during	during	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	first	first	_	_	_	_	_	_	_
13	18	18	_	_	_	_	_	_	_
14	h	h	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	steroid	steroid	_	_	_	_	_	_	_
17	treatment	treatment	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	as	as	_	_	_	_	_	_	_
20	effective	effective	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	blocking	block	_	_	_	_	_	_	_
23	chromatin	chromatin	_	_	_	_	_	_	_
24	fragmentation	fragmentation	_	_	_	_	_	_	_
25	as	as	_	_	_	_	_	_	_
26	inhibition	inhibition	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	entire	entire	_	_	_	_	_	_	_
30	period	period	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	suggesting	suggest	_	_	_	_	_	_	_
33	that	that	_	_	_	_	_	_	_
34	synthesis	synthesis	_	_	_	_	_	_	_
35	of	of	_	_	_	_	_	_	_
36	a	a	_	_	_	_	_	_	_
37	component	component	_	_	_	_	_	_	_
38	with	with	_	_	_	_	_	_	_
39	a	a	_	_	_	_	_	_	_
40	rapid	rapid	_	_	_	_	_	_	_
41	turnover	turnover	_	_	_	_	_	_	_
42	rate	rate	_	_	_	_	_	_	_
43	is	be	_	_	_	_	_	_	_
44	required	require	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	Dexamethasone	Dexamethasone	_	_	_	_	_	_	_
2	treatment	treatment	_	_	_	_	_	_	_
3	completely	completely	_	_	_	_	_	_	_
4	blocked	block	_	_	_	_	_	_	_
5	12-O-tetradecanoylphorbol	12-O-tetradecanoylphorbol	_	_	_	_	_	_	_
6	13-acetate	13-acetate	_	_	_	_	_	_	_
7	induction	induction	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	factor-kappaB	factor-kappaB	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	elicited	elicit	_	_	_	_	_	_	_
17	an	an	_	_	_	_	_	_	_
18	increase	increase	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	amount	amount	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	immunoreactive	immunoreactive	_	_	_	_	_	_	_
24	IkappaB	IkappaB	_	_	_	_	_	_	_
25	alpha	alpha	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	sensitive	sensitive	_	_	_	_	_	_	_
28	6TG1.1	6tg1.1	_	_	_	_	_	_	_
29	cells	cell	_	_	_	_	_	_	_
30	but	but	_	_	_	_	_	_	_
31	not	not	_	_	_	_	_	_	_
32	in	in	_	_	_	_	_	_	_
33	resistant	resistant	_	_	_	_	_	_	_
34	ICR27TK.3	icr27tk.3	_	_	_	_	_	_	_
35	cells	cell	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	mild	mild	_	_	_	_	_	_	_
5	detergent	detergent	_	_	_	_	_	_	_
6	treatment	treatment	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	cell	cell	_	_	_	_	_	_	_
9	extracts	extract	_	_	_	_	_	_	_
10	indicated	indicate	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	substantial	substantial	_	_	_	_	_	_	_
14	amount	amount	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
17	NF-kappaB	nf-kappab	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	complexed	complexe	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	IkappaB	IkappaB	_	_	_	_	_	_	_
22	alpha	alpha	_	_	_	_	_	_	_
23	or	or	_	_	_	_	_	_	_
24	some	some	_	_	_	_	_	_	_
25	other	other	_	_	_	_	_	_	_
26	inhibitory	inhibitory	_	_	_	_	_	_	_
27	factor	factor	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	induction	induction	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	labile	labile	_	_	_	_	_	_	_
9	inhibitory	inhibitory	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	such	such	_	_	_	_	_	_	_
12	as	as	_	_	_	_	_	_	_
13	IkappaB	IkappaB	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	may	may	_	_	_	_	_	_	_
16	contribute	contribute	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	glucocorticoid-induced	glucocorticoid-induced	_	_	_	_	_	_	_
19	apoptosis	apoptosis	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

